0310-1349 : Tagrisso 40 1/1 Oral Tablet, Film Coated
NDC: | 0310-1349 |
Labeler: | Astrazeneca Pharmaceuticals Lp |
Product Type: | Human Prescription Drug |
Drug Name: | Tagrisso |
Dosage Form: | Oral Tablet, Film Coated |
Application #: | NDA208065 |
Rev. Date: |
Appearance:
Markings: | AZ;40 |
Shapes: |
Round |
Colors: |
Brown |
Size (mm): | 9 |
Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. |
NDC Package Codes:
- 0310-1349-30: 30 TABLET, FILM COATED IN 1 BOTTLE (0310‑1349‑30)
Active Ingredients:
- Osimertinib
Dosage Strength:
- 40 1/1
Inactive Ingredients:
- Mannitol
- Cellulose, Microcrystalline
- Sodium Stearyl Fumarate
- Polyvinyl Alcohol
- Titanium Dioxide
- Polyethylene Glycol 3350
- Talc
- Ferric Oxide Yellow
- Ferric Oxide Red
- Ferrosoferric Oxide
- Hydroxypropyl Cellulose, Low Substituted
Pharmaceutical Classes:
- Kinase Inhibitor [EPC]
- Kinase Inhibitors [MoA]
- Cytochrome P450 3A Inhibitors [MoA]
- Cytochrome P450 3A4 Inducers [MoA]
- Cytochrome P450 1A2 Inducers [MoA]
- Breast Cancer Resistance Protein Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 0310-1350 Tagrisso 80 1/1 Oral Tablet, Film Coated by Astrazeneca Pharmaceuticals Lp
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 0310-1222Next: 0310-1350 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.